Iovance Biotherapeutics, Inc. (IOVA)
USD 3.25
(6.05%)
USD 3.25
(6.05%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -460.55 Million USD | -15.46% |
| 2022 | -398.87 Million USD | -16.39% |
| 2021 | -342.7 Million USD | -30.83% |
| 2020 | -261.93 Million USD | -26.62% |
| 2019 | -206.87 Million USD | -61.29% |
| 2018 | -128.25 Million USD | -38.09% |
| 2017 | -92.87 Million USD | -73.15% |
| 2016 | -53.63 Million USD | -92.53% |
| 2015 | -27.86 Million USD | -131.39% |
| 2014 | -12.04 Million USD | 46.82% |
| 2013 | -22.64 Million USD | -178.4% |
| 2012 | -8.13 Million USD | 61.67% |
| 2011 | -21.21 Million USD | -2502.16% |
| 2010 | -815.41 Thousand USD | -5070.0% |
| 2009 | -15.77 Thousand USD | 72.4% |
| 2008 | -57.14 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -117.72 Million USD | 2.91% |
| 2024 Q2 | -101.91 Million USD | 13.43% |
| 2023 Q3 | -118.36 Million USD | -7.52% |
| 2023 FY | -460.55 Million USD | -15.46% |
| 2023 Q1 | -110.85 Million USD | -3.57% |
| 2023 Q2 | -110.08 Million USD | 0.69% |
| 2023 Q4 | -121.25 Million USD | -2.45% |
| 2022 Q3 | -100.39 Million USD | -0.66% |
| 2022 FY | -398.87 Million USD | -16.39% |
| 2022 Q1 | -91.71 Million USD | 7.79% |
| 2022 Q2 | -99.73 Million USD | -8.75% |
| 2022 Q4 | -107.03 Million USD | -6.61% |
| 2021 Q3 | -86.24 Million USD | -5.91% |
| 2021 Q4 | -99.46 Million USD | -15.33% |
| 2021 FY | -342.7 Million USD | -30.83% |
| 2021 Q1 | -75.57 Million USD | -10.27% |
| 2021 Q2 | -81.42 Million USD | -7.75% |
| 2020 FY | -261.93 Million USD | -26.62% |
| 2020 Q4 | -68.53 Million USD | -16.23% |
| 2020 Q2 | -63.62 Million USD | 10.14% |
| 2020 Q1 | -70.81 Million USD | -8.75% |
| 2020 Q3 | -58.96 Million USD | 7.33% |
| 2019 Q3 | -51.61 Million USD | -2.88% |
| 2019 Q2 | -50.16 Million USD | -25.46% |
| 2019 Q4 | -65.11 Million USD | -26.16% |
| 2019 FY | -206.87 Million USD | -61.29% |
| 2019 Q1 | -39.98 Million USD | -14.43% |
| 2018 Q2 | -31.37 Million USD | -16.75% |
| 2018 FY | -128.25 Million USD | -38.09% |
| 2018 Q4 | -34.94 Million USD | 0.33% |
| 2018 Q3 | -35.06 Million USD | -11.73% |
| 2018 Q1 | -26.87 Million USD | -3.09% |
| 2017 FY | -92.87 Million USD | -73.15% |
| 2017 Q1 | -20.88 Million USD | -31.14% |
| 2017 Q2 | -23.58 Million USD | -12.93% |
| 2017 Q3 | -22.34 Million USD | 5.25% |
| 2017 Q4 | -26.07 Million USD | -16.69% |
| 2016 Q3 | -18.97 Million USD | -61.84% |
| 2016 Q2 | -11.72 Million USD | -67.29% |
| 2016 Q1 | -7.01 Million USD | 22.4% |
| 2016 Q4 | -15.92 Million USD | 16.1% |
| 2016 FY | -53.63 Million USD | -92.53% |
| 2015 FY | -27.86 Million USD | -131.39% |
| 2015 Q4 | -9.03 Million USD | -18.2% |
| 2015 Q3 | -7.64 Million USD | -18.68% |
| 2015 Q2 | -6.44 Million USD | -21.56% |
| 2015 Q1 | -5.29 Million USD | -8.83% |
| 2014 Q4 | -4.86 Million USD | -73.71% |
| 2014 Q3 | -2.8 Million USD | -32.81% |
| 2014 Q2 | -2.11 Million USD | 6.61% |
| 2014 Q1 | -2.25 Million USD | 80.35% |
| 2014 FY | -12.04 Million USD | 46.82% |
| 2013 Q1 | -704.91 Thousand USD | 59.08% |
| 2013 Q2 | -1.02 Million USD | -46.01% |
| 2013 Q3 | -9.4 Million USD | -814.16% |
| 2013 Q4 | -11.49 Million USD | -22.2% |
| 2013 FY | -22.64 Million USD | -178.4% |
| 2012 Q4 | -1.72 Million USD | -5.84% |
| 2012 Q3 | -1.62 Million USD | 1.14% |
| 2012 FY | -8.13 Million USD | 61.67% |
| 2012 Q2 | -1.64 Million USD | 47.5% |
| 2012 Q1 | -3.13 Million USD | 25.06% |
| 2011 Q4 | -4.18 Million USD | 28.02% |
| 2011 Q1 | -658.25 Thousand USD | -32.69% |
| 2011 Q2 | -10.56 Million USD | -1504.43% |
| 2011 Q3 | -5.81 Million USD | 44.95% |
| 2011 FY | -21.21 Million USD | -2502.16% |
| 2010 Q1 | -67.68 Thousand USD | -2786.14% |
| 2010 FY | -815.41 Thousand USD | -5070.0% |
| 2010 Q4 | -496.07 Thousand USD | -197.0% |
| 2010 Q3 | -167.02 Thousand USD | -97.36% |
| 2010 Q2 | -84.62 Thousand USD | -25.04% |
| 2009 Q1 | -6612.00 USD | 53.88% |
| 2009 Q2 | -3345.00 USD | 49.41% |
| 2009 Q3 | -3470.00 USD | -3.74% |
| 2009 Q4 | -2345.00 USD | 32.42% |
| 2009 FY | -15.77 Thousand USD | 72.4% |
| 2008 FY | -57.14 Thousand USD | 0.0% |
| 2008 Q4 | -14.33 Thousand USD | -480.25% |
| 2008 Q1 | -25.29 Thousand USD | 0.0% |
| 2008 Q2 | -15.03 Thousand USD | 40.56% |
| 2008 Q3 | -2471.00 USD | 83.57% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Caribou Biosciences, Inc. | -116.05 Million USD | -296.832% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -2192.503% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -1244.031% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | -808.526% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | -175.27% |
| C4 Therapeutics, Inc. | -139.03 Million USD | -231.264% |
| Agenus Inc. | -159.54 Million USD | -188.663% |
| Fortress Biotech, Inc. | -142.34 Million USD | -223.558% |
| GlycoMimetics, Inc. | -39.27 Million USD | -1072.643% |
| Novavax, Inc. | -566.51 Million USD | 18.703% |
| Keros Therapeutics, Inc. | -169.94 Million USD | -171.011% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -38537.5% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -376.227% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -14465.433% |
| Akebia Therapeutics, Inc. | -46.25 Million USD | -895.674% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | -63.218% |
| AlloVir, Inc. | -181.33 Million USD | -153.988% |
| Aptorum Group Limited | -10.52 Million USD | -4276.552% |
| Ardelyx, Inc. | -63.27 Million USD | -627.857% |
| Bicycle Therapeutics plc | -189.94 Million USD | -142.468% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | -168.107% |
| Chimerix, Inc. | -93.06 Million USD | -394.879% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -921.709% |
| CRISPR Therapeutics AG | -222.53 Million USD | -106.957% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -1753.804% |
| Precision BioSciences, Inc. | -43.73 Million USD | -953.043% |
| Dyadic International, Inc. | -8.22 Million USD | -5496.277% |
| Elevation Oncology, Inc. | -45.44 Million USD | -913.443% |
| Fortress Biotech, Inc. | -142.34 Million USD | -223.558% |
| GT Biopharma, Inc. | -13.57 Million USD | -3292.45% |
| Alkermes plc | 414.12 Million USD | 211.213% |
| Immix Biopharma, Inc. | -16.14 Million USD | -2753.329% |
| Innoviva, Inc. | 176.7 Million USD | 360.631% |
| IO Biotech, Inc. | -91.44 Million USD | -403.657% |
| Jaguar Health, Inc. | -34.29 Million USD | -1243.09% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 3956.632% |
| ContextLogic Inc. | -328 Million USD | -40.414% |
| AbCellera Biologics Inc. | -237.2 Million USD | -94.159% |
| Lantern Pharma Inc. | -17.87 Million USD | -2476.183% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -5317.704% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | -124.661% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | -21.042% |
| MEI Pharma, Inc. | 14.54 Million USD | 3267.095% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -448.846% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -1794.789% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -250.275% |
| NextCure, Inc. | -67.63 Million USD | -580.928% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -371.43% |
| ChromaDex Corporation | -5.59 Million USD | -8125.737% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -242.604% |
| Incyte Corporation | 620.52 Million USD | 174.221% |
| Opthea Limited | -191.84 Million USD | -140.071% |
| MiMedx Group, Inc. | 37.11 Million USD | 1340.864% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -766.912% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -540.261% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -16636.493% |
| Vaxcyte, Inc. | -468.04 Million USD | 1.599% |
| PDS Biotechnology Corporation | -43.04 Million USD | -969.942% |
| Pharming Group N.V. | -4.87 Million USD | -9338.566% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -1447.785% |
| Onconetix, Inc. | -36.03 Million USD | -1178.102% |
| Acelyrin, Inc. | -422.06 Million USD | -9.121% |
| PureTech Health plc | -146.19 Million USD | -215.022% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -460.318% |
| Avidity Biosciences, Inc. | -235.59 Million USD | -95.485% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -2271.752% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -1794.789% |
| ESSA Pharma Inc. | -32.13 Million USD | -1333.241% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -2147.616% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -4260.115% |
| Seer, Inc. | -103.46 Million USD | -345.144% |
| Sangamo Therapeutics, Inc. | -274 Million USD | -68.084% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -1116.19% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -1471.606% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -3571525.769% |
| Summit Therapeutics Inc. | -89.73 Million USD | -413.238% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -1142.605% |
| Senti Biosciences, Inc. | -92.72 Million USD | -396.683% |
| ImmuCell Corporation | -5.74 Million USD | -7912.4% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -257.056% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -531.084% |
| Precigen, Inc. | -88.92 Million USD | -417.93% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -711.429% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -1004.087% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -301.278% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -946.487% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -11583.242% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | 8.676% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -600.374% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -1294.746% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1474.13% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -2525.914% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -577.332% |
| Fate Therapeutics, Inc. | -190.51 Million USD | -141.749% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | -6576.703% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | -110.089% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 630.525% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -794.185% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -4534.488% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | -77.371% |
| Aptose Biosciences Inc. | -52.35 Million USD | -779.668% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -3093.719% |
| Soligenix, Inc. | -7.69 Million USD | -5882.886% |
| Century Therapeutics, Inc. | -146.54 Million USD | -214.276% |
| Kura Oncology, Inc. | -165.8 Million USD | -177.773% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -392.798% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -5436.23% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -18458.662% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -7003.007% |
| Autolus Therapeutics plc | -195.02 Million USD | -136.15% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -444.029% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -525.233% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -2079.129% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | -102.858% |
| GRI Bio, Inc. | -11.38 Million USD | -3944.603% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -10099.027% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -251.055% |
| IGM Biosciences, Inc. | -263.46 Million USD | -74.811% |
| INmune Bio, Inc. | -29.74 Million USD | -1448.566% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -316.362% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -1109.6% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -2782.212% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -2820.322% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -653.804% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -328.339% |
| Atara Biotherapeutics, Inc. | -276 Million USD | -66.866% |
| Coherus BioSciences, Inc. | -203.19 Million USD | -126.654% |
| Verastem, Inc. | -92.08 Million USD | -400.151% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -877.106% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | -150.107% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -289.051% |
| Histogen Inc. | -10.64 Million USD | -4227.342% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -2876.733% |
| Surrozen, Inc. | -45.78 Million USD | -906.027% |
| Organovo Holdings, Inc. | -15.08 Million USD | -2952.89% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -8947.891% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -676.902% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -797.881% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -1721.831% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -5933.912% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | -168.888% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -850.626% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -488.912% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -2925.858% |
| Apollomics, Inc. | -54.83 Million USD | -739.915% |
| Amarin Corporation plc | -67.58 Million USD | -581.421% |
| Mesoblast Limited | -58.79 Million USD | -683.344% |
| Turnstone Biologics Corp. | -59.03 Million USD | -680.185% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | -178.233% |
| Synaptogenix, Inc. | -8.31 Million USD | -5439.657% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -3057.541% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -402.295% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -9512.069% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -5115.114% |
| Exelixis, Inc. | 170.88 Million USD | 369.514% |
| Better Therapeutics, Inc. | -38.26 Million USD | -1103.698% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | -197.014% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | 10.938% |
| NLS Pharmaceutics AG | -11.8 Million USD | -3800.708% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -5626.988% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | -1435.555% |
| Gritstone bio, Inc. | -154.63 Million USD | -197.838% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -568.824% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -2589.702% |
| Avid Bioservices, Inc. | -18.67 Million USD | -2365.783% |
| Insmed Incorporated | -709.62 Million USD | 35.098% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -2835.406% |
| MediWound Ltd. | -15.29 Million USD | -2912.158% |
| OmniAb, Inc. | -69.41 Million USD | -563.448% |
| Alector, Inc. | -151.74 Million USD | -203.519% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -326.511% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -783.177% |
| Zai Lab Limited | -366.57 Million USD | -25.639% |
| Revance Therapeutics, Inc. | -316.77 Million USD | -45.389% |
| Aura Biosciences, Inc. | -84.99 Million USD | -441.891% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | -87.601% |
| Immunic, Inc. | -99.22 Million USD | -364.166% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | -221.714% |
| Veracyte, Inc. | -85.79 Million USD | -436.813% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | -63.426% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -3141.091% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -6586.448% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -2350.744% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 179.602% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -1709.449% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 1286.947% |
| TG Therapeutics, Inc. | 20.63 Million USD | 2332.148% |
| Galecto, Inc. | -39.9 Million USD | -1054.139% |
| Calithera Biosciences, Inc. | -42.07 Million USD | -994.64% |
| Fortrea Holdings Inc. | 63.1 Million USD | 829.887% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | -227.928% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -1494.844% |
| XBiotech Inc. | -37.51 Million USD | -1127.83% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -568.824% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -586.173% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -326.815% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -1694.013% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -764.218% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | 19.088% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -486.759% |
| Vaxxinity, Inc. | -58.28 Million USD | -690.184% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -344.088% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -1969.637% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -432.956% |
| NexImmune, Inc. | -29.19 Million USD | -1477.663% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -8094.808% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -3058.542% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 111.38% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -1709.022% |
| Scopus BioPharma Inc. | -11.71 Million USD | -3831.403% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -262.468% |
| Ainos, Inc. | -13.2 Million USD | -3387.394% |
| Pluri Inc. | -22.15 Million USD | -1978.522% |
| Prothena Corporation plc | -191.03 Million USD | -141.085% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | -233.647% |
| Celularity Inc. | -192.28 Million USD | -139.516% |
| Rallybio Corporation | -78.93 Million USD | -483.488% |
| Cue Biopharma, Inc. | -52.14 Million USD | -783.16% |
| MeiraGTx Holdings plc | -137.06 Million USD | -236.025% |
| Omeros Corporation | -164.53 Million USD | -179.924% |
| Humacyte, Inc. | -100.04 Million USD | -360.343% |
| Immunocore Holdings plc | -59.64 Million USD | -672.115% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -2381.594% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -1781.138% |
| Blueprint Medicines Corporation | -486.27 Million USD | 5.289% |
| CalciMedica, Inc. | -21.87 Million USD | -2005.413% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -516.875% |
| Scholar Rock Holding Corporation | -171.29 Million USD | -168.869% |
| Sana Biotechnology, Inc. | -326.9 Million USD | -40.887% |
| Pulmatrix, Inc. | -14.74 Million USD | -3024.552% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -1188.457% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -418.262% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | 10.622% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -581.794% |
| Cytokinetics, Incorporated | -496.2 Million USD | 7.184% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | -1238.095% |
| Nutriband Inc. | -4.87 Million USD | -9353.325% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -956.013% |
| Vor Biopharma Inc. | -126.03 Million USD | -265.419% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 110.857% |
| Evogene Ltd. | -26.39 Million USD | -1645.137% |
| ProKidney Corp. | -151.52 Million USD | -203.955% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -613.658% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -5887.318% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | 24.172% |
| CorMedix Inc. | -48.95 Million USD | -840.727% |
| BioLineRx Ltd. | -49.69 Million USD | -826.79% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -303.387% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -1109.705% |
| Atai Life Sciences N.V. | -125.47 Million USD | -267.064% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -464.139% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -465.735% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | -84.972% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1398.24% |
| MediciNova, Inc. | -9.9 Million USD | -4551.987% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -264.444% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -6259.152% |
| GeoVax Labs, Inc. | -26.74 Million USD | -1622.17% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | -98.667% |
| Biomea Fusion, Inc. | -126.13 Million USD | -265.132% |
| PTC Therapeutics, Inc. | -349.4 Million USD | -31.813% |
| Mereo BioPharma Group plc | -28.41 Million USD | -1520.774% |
| Cullinan Oncology, Inc. | -191.08 Million USD | -141.018% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | -100.283% |
| Absci Corporation | -115.51 Million USD | -298.701% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1569.478% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -308.055% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | -90.186% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -1727.905% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | -121.429% |
| Allakos Inc. | -196.05 Million USD | -134.912% |
| Imunon, Inc. | -21.03 Million USD | -2089.965% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -316.178% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 529.298% |
| BioAtla, Inc. | -129.68 Million USD | -255.131% |
| NLS Pharmaceutics AG | -11.8 Million USD | -3800.708% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | -2807.019% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | -40.527% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -1002.924% |
| XOMA Corporation | -41.84 Million USD | -1000.552% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -337.64% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -279.077% |
| aTyr Pharma, Inc. | -54.91 Million USD | -738.615% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -426.793% |
| Akero Therapeutics, Inc. | -172.87 Million USD | -166.419% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | -81.002% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -2045.528% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -5507.85% |
| Akari Therapeutics, Plc | -16.8 Million USD | -2640.444% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -5208058.29% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 236.432% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -6948.629% |
| UroGen Pharma Ltd. | -65.53 Million USD | -602.757% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -415.871% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -6241.157% |
| Orgenesis Inc. | -53.63 Million USD | -758.675% |
| Entera Bio Ltd. | -8.89 Million USD | -5080.058% |
| GH Research PLC | -41.22 Million USD | -1017.265% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -1691.501% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -454.536% |
| Xencor, Inc. | -138.63 Million USD | -232.2% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -8834.942% |
| Replimune Group, Inc. | -234.77 Million USD | -96.172% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -2043.02% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -3201.025% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -6948.629% |
| Portage Biotech Inc. | -18.25 Million USD | -2423.196% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -6259.152% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -338.791% |
| OncoCyte Corporation | -25.13 Million USD | -1732.268% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -3973.992% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -3919.87% |
| Purple Biotech Ltd. | 22.27 Million USD | 2167.976% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -6030.977% |
| scPharmaceuticals Inc. | -55.39 Million USD | -731.394% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -2337.118% |
| HilleVax, Inc. | -133.34 Million USD | -245.389% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -3722.384% |
| Tharimmune, Inc. | -9.45 Million USD | -4770.95% |
| Genprex, Inc. | -31.07 Million USD | -1382.061% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | -144.726% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -1367.824% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -60103.791% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -8355.404% |
| OKYO Pharma Limited | -15.74 Thousand USD | -2924134.257% |
| Savara Inc. | -60 Million USD | -667.509% |
| Curis, Inc. | -48.33 Million USD | -852.907% |
| Daré Bioscience, Inc. | -30.83 Million USD | -1393.388% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -8727.569% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -6228.968% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -1590.125% |
| BeiGene, Ltd. | -1.2 Billion USD | 61.866% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | -2209.805% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | 5.465% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -391.777% |
| Erasca, Inc. | -141.52 Million USD | -225.426% |
| bluebird bio, Inc. | -244.26 Million USD | -88.551% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -10073.661% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 336.863% |
| DBV Technologies S.A. | -76.43 Million USD | -502.574% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -10073.661% |
| Moderna, Inc. | -4.23 Billion USD | 89.135% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -980.896% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -7141.494% |
| Molecular Templates, Inc. | -10.46 Million USD | -4300.526% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -584.979% |
| Travere Therapeutics, Inc. | -376.74 Million USD | -22.247% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | -221.37% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -785.81% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | -198.015% |
| Cogent Biosciences, Inc. | -208.13 Million USD | -121.284% |
| MacroGenics, Inc. | -168.24 Million USD | -173.745% |
| RenovoRx, Inc. | -11.39 Million USD | -3941.409% |
| Adicet Bio, Inc. | -152.03 Million USD | -202.924% |
| Prime Medicine, Inc. | -191.29 Million USD | -140.762% |
| Aditxt, Inc. | -26.06 Million USD | -1667.138% |
| Adagene Inc. | -23.71 Million USD | -1841.659% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6200.312% |
| Quantum-Si incorporated | -111.17 Million USD | -314.28% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -1355.255% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -3059.325% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 477.464% |
| SciSparc Ltd. | -5.77 Million USD | -7877.81% |
| Vericel Corporation | -6.46 Million USD | -7024.985% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -5220.283% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -1892.074% |
| Generation Bio Co. | -138.56 Million USD | -232.382% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -454.69% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -432.684% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | -91.023% |
| Invivyd, Inc. | -207.78 Million USD | -121.654% |
| Relay Therapeutics, Inc. | -373 Million USD | -23.474% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -4810.794% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 2244.03% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -4377.097% |
| 2seventy bio, Inc. | -216.7 Million USD | -112.53% |
| ADMA Biologics, Inc. | 21.63 Million USD | 2229.063% |
| Clene Inc. | -40.54 Million USD | -1036.061% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -1812.791% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -740.497% |
| GeoVax Labs, Inc. | -26.74 Million USD | -1622.17% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | -31.566% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -1153.835% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 2964.707% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -344.118% |
| Finch Therapeutics Group, Inc. | -34 Million USD | -1254.506% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | -170.475% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 32.697% |
| Evaxion Biotech A/S | -22.19 Million USD | -1974.87% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -459.053% |
| Verve Therapeutics, Inc. | -223.12 Million USD | -106.414% |
| Trevena, Inc. | -35.28 Million USD | -1205.143% |
| Surrozen, Inc. | -45.78 Million USD | -906.027% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -476.095% |
| Cingulate Inc. | -22.75 Million USD | -1923.618% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 6247.344% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -931.095% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -5493.421% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -349.072% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -527.644% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -641.952% |
| Clearmind Medicine Inc. | -8.74 Million USD | -5168.74% |
| Kronos Bio, Inc. | -121.83 Million USD | -278.034% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -504.44% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -15602.74% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -356.781% |
| Statera Biopharma, Inc. | -98.34 Million USD | -368.315% |
| ImmunityBio, Inc. | -362.25 Million USD | -27.138% |
| Korro Bio, Inc. | -84.53 Million USD | -444.821% |
| Kineta, Inc. | -15.72 Million USD | -2829.206% |
| BioVie Inc. | -32.17 Million USD | -1331.215% |
| Codexis, Inc. | -68.06 Million USD | -576.606% |
| Celularity Inc. | -192.28 Million USD | -139.516% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | -106.892% |
| Celcuity Inc. | -66.23 Million USD | -595.39% |
| Virax Biolabs Group Limited | -6.49 Million USD | -6989.37% |
| Cibus, Inc. | -318.88 Million USD | -44.429% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -971.067% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | -1260.829% |
| IN8bio, Inc. | -30.33 Million USD | -1418.143% |
| Kodiak Sciences Inc. | -277.32 Million USD | -66.074% |
| Annexon, Inc. | -143.72 Million USD | -220.449% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -272.046% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -612.432% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -1864.507% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | -30.201% |
| Eyenovia, Inc. | -25.4 Million USD | -1712.764% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 1511.026% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -8180.457% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -482.006% |
| Arcellx, Inc. | -89.88 Million USD | -412.415% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -914.179% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | -235.667% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -1380.469% |
| Moolec Science SA | -6.65 Million USD | -6821.739% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -653.311% |
| Geron Corporation | -193.94 Million USD | -137.47% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -964.802% |
| Royalty Pharma plc | 1.49 Billion USD | 130.865% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | -180.552% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -4837.453% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -2003.522% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | -169.4% |
| Humacyte, Inc. | -100.04 Million USD | -360.343% |
| Structure Therapeutics Inc. | -102.77 Million USD | -348.124% |
| 89bio, Inc. | -151.2 Million USD | -204.594% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -474.75% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -3067.531% |
| Genelux Corporation | -24.16 Million USD | -1805.893% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -1257.66% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | -168.157% |
| Notable Labs, Ltd. | -14.65 Million USD | -3042.246% |
| Liquidia Corporation | -73.38 Million USD | -527.601% |
| Mustang Bio, Inc. | -50.72 Million USD | -807.935% |
| Immunovant, Inc. | -282.7 Million USD | -62.909% |
| Quantum-Si incorporated | -111.17 Million USD | -314.28% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -489.682% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -2065.604% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -351.475% |
| Acasti Pharma Inc. | -11.31 Million USD | -3971.42% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -1909.323% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -2782.212% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | -115.16% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -12452.466% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -2799.15% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -1479.583% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -1012.891% |
| PepGen Inc. | -84.76 Million USD | -443.33% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -1454.315% |
| United Therapeutics Corporation | 1.18 Billion USD | 138.869% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -1911.438% |
| Solid Biosciences Inc. | -104.31 Million USD | -341.508% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -1303.796% |
| Immuneering Corporation | -58.41 Million USD | -688.454% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -8947.891% |
| Silo Pharma, Inc. | -3.85 Million USD | -11845.221% |
| Belite Bio, Inc | -31.66 Million USD | -1354.336% |
| XOMA Corporation | -41.84 Million USD | -1000.552% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -582.108% |
| Bionomics Limited | -17.89 Billion USD | 97.426% |
| Apogee Therapeutics, Inc. | -93 Million USD | -395.209% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1390.804% |
| uniQure N.V. | -282.87 Million USD | -62.816% |
| Cassava Sciences, Inc. | -105.95 Million USD | -334.666% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6200.312% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -255.633% |
| Forte Biosciences, Inc. | -32.48 Million USD | -1317.715% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -5443.057% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -1466.794% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -8180.457% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -3141.091% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -5081.224% |
| Altimmune, Inc. | -95.92 Million USD | -380.104% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -526.662% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1390.804% |
| Compugen Ltd. | -12.99 Million USD | -3444.943% |
| Peak Bio, Inc. | -1356.23 USD | -33958668.056% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -828.471% |
| Benitec Biopharma Inc. | -22.49 Million USD | -1947.839% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -90.076% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -1448.306% |
| Zura Bio Limited | -62.63 Million USD | -635.271% |
| PolyPid Ltd. | -22.86 Million USD | -1914.077% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -2729.682% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -1448.306% |
| Instil Bio, Inc. | -159.16 Million USD | -189.352% |
| argenx SE | -425.04 Million USD | -8.354% |
| Immunome, Inc. | -109.53 Million USD | -320.487% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -814.479% |
| Verona Pharma plc | -67.83 Million USD | -578.981% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -1667.302% |
| Shattuck Labs, Inc. | -91.95 Million USD | -400.842% |
| CervoMed Inc. | -7.81 Million USD | -5794.857% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -529.953% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -3357.391% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -856.032% |
| Moolec Science SA | -6.65 Million USD | -6821.739% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -2700.016% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | -240.583% |
| AnaptysBio, Inc. | -164.41 Million USD | -180.127% |
| Design Therapeutics, Inc. | -78.19 Million USD | -489.025% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -429.129% |
| NeurAxis, Inc. | -6.66 Million USD | -6810.636% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -1037.211% |
| Lumos Pharma, Inc. | -36.61 Million USD | -1157.877% |
| Achilles Therapeutics plc | -75.25 Million USD | -511.998% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -1667.302% |
| 180 Life Sciences Corp. | -13.47 Million USD | -3317.244% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 9031.948% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -15602.74% |
| Nutriband Inc. | -4.87 Million USD | -9353.325% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -315.742% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -730.599% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -805.97% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -596.772% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -750.947% |
| Palisade Bio, Inc. | -13.07 Million USD | -3423.787% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -914.246% |
| Beam Therapeutics Inc. | -176.48 Million USD | -160.962% |
| Neurogene Inc. | -55.58 Million USD | -728.597% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -321.935% |
| AEON Biopharma, Inc. | -48.42 Million USD | -850.998% |
| Sesen Bio, Inc. | -25.9 Million USD | -1677.602% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -451.376% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -3559.036% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -535.789% |
| Athira Pharma, Inc. | -125.46 Million USD | -267.079% |
| Vaccinex, Inc. | -22.88 Million USD | -1912.493% |
| HCW Biologics Inc. | -25.71 Million USD | -1690.863% |
| XOMA Corporation | -41.84 Million USD | -1000.552% |
| Nektar Therapeutics | -137.42 Million USD | -235.135% |
| Arvinas, Inc. | -401.5 Million USD | -14.71% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -5208058.29% |
| Merus N.V. | -156.54 Million USD | -194.199% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -359.36% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -1230.326% |
| Rezolute, Inc. | -70.42 Million USD | -553.989% |
| Clene Inc. | -40.54 Million USD | -1036.061% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -2711.977% |
| BeyondSpring Inc. | -23.11 Million USD | -1892.554% |
| Synlogic, Inc. | -55.16 Million USD | -734.936% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -2468.794% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -4154.98% |
| Peak Bio, Inc. | -1356.23 USD | -33958668.056% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -1037.098% |
| Krystal Biotech, Inc. | -109.72 Million USD | -319.732% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -255.534% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | -34.269% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -9604.247% |
| MannKind Corporation | 8.67 Million USD | 5407.202% |
| Ikena Oncology, Inc. | -75.41 Million USD | -510.683% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -4674.116% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -585.05% |
| Gossamer Bio, Inc. | -183.75 Million USD | -150.632% |
| CohBar, Inc. | -12.38 Million USD | -3617.694% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -807.971% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1569.478% |
| Legend Biotech Corporation | -439.48 Million USD | -4.795% |
| Mural Oncology plc | -194.63 Million USD | -136.623% |
| Biora Therapeutics, Inc. | -67.14 Million USD | -585.937% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -2752.594% |
| Disc Medicine, Inc. | -91.12 Million USD | -405.415% |
| Champions Oncology, Inc. | -7.35 Million USD | -6160.998% |
| REGENXBIO Inc. | -268.12 Million USD | -71.768% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -4196.986% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -726.026% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -1082.113% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -302.738% |
| Vaxart, Inc. | -83.34 Million USD | -452.58% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -5305.617% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -976.221% |
| Cellectis S.A. | -106.62 Million USD | -331.939% |
| Longeveron Inc. | -21.02 Million USD | -2090.114% |
| Repare Therapeutics Inc. | -116.22 Million USD | -296.268% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | -71.963% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -508.843% |
| Revolution Medicines, Inc. | -487.18 Million USD | 5.465% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -6823.617% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -947.82% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -517.454% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -561.39% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -4082.717% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 110.692% |
| Denali Therapeutics Inc. | -196.69 Million USD | -134.144% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -5220.283% |
| Veru Inc. | -93.78 Million USD | -391.094% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -1874.191% |
| Cingulate Inc. | -22.75 Million USD | -1923.618% |
| Passage Bio, Inc. | -108.38 Million USD | -324.913% |
| Context Therapeutics Inc. | -25.07 Million USD | -1736.9% |
| Exicure, Inc. | -14.99 Million USD | -2971.212% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -123.503% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -1034.438% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -4639.755% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | -149.819% |
| Nuvalent, Inc. | -149.49 Million USD | -208.083% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -5505.288% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -419.051% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -2116.997% |
| OmniAb, Inc. | -69.41 Million USD | -563.448% |
| Anew Medical, Inc. | -1.3 Million USD | -35304.738% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -3506.288% |
| Lipocine Inc. | -17.93 Million USD | -2468.513% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -572.221% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -504.789% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -1109.6% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -1065.176% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -1957.537% |
| Sage Therapeutics, Inc. | -579.84 Million USD | 20.573% |
| Ocugen, Inc. | -65.53 Million USD | -602.811% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -390.656% |
| Q32 Bio Inc. | -92.1 Million USD | -400.053% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -2048.23% |
| Alumis Inc. Common Stock | -158.17 Million USD | -191.172% |
| Equillium, Inc. | -14.52 Million USD | -3071.457% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -638.004% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -5727.39% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -2341.327% |
| Galera Therapeutics, Inc. | -46.95 Million USD | -880.935% |
| Evelo Biosciences, Inc. | -108.46 Million USD | -324.611% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | -3747.606% |
| Dominari Holdings Inc. | -21.79 Million USD | -2013.044% |
| Edesa Biotech, Inc. | -9.22 Million USD | -4893.723% |
| vTv Therapeutics Inc. | -25.5 Million USD | -1705.972% |
| Bio-Techne Corporation | 206.68 Million USD | 322.83% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | -17.643% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 339.837% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -248.178% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -1099.654% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -204.802% |
| Nkarta, Inc. | -131.65 Million USD | -249.836% |
| BioCardia, Inc. | -11.64 Million USD | -3855.333% |
| Iterum Therapeutics plc | -47.46 Million USD | -870.252% |